Studies on hepatoprotective, antispasmodic and calcium antagonist activities of the aqueous-methanol extract of Achillea millefolium

Phytotherapy Research

Volumn 20, Issue 7, 2006, Pages 546-551

  Yaeesh, Sheikh ^a   Jamal, Qamar ^a   Khan, Arif Ullah ^b   Gilani, Anwarul Hassan ^b  

^a ZIAUDDIN MEDICAL UNIVERSITY   (Pakistan)

^b AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

Author keywords

Achillea millefolium; Antispasmodic; Calcium antagonist; Hepatoprotective

Indexed keywords

ACHILLEA MILLEFOLIUM EXTRACT; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIUM ANTAGONIST; GALACTOSAMINE; LIPOPOLYSACCHARIDE; METHANOL; SPASMOLYTIC AGENT; VERAPAMIL;

ACHILLEA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG USE; HEPATITIS; HISTOPATHOLOGY; LIVER PROTECTION; MORTALITY; MOUSE; NONHUMAN; SMOOTH MUSCLE CONTRACTION;

ACHILLEA; ANIMALS; CALCIUM CHANNEL BLOCKERS; FEMALE; GASTROINTESTINAL MOTILITY; JEJUNUM; LIVER; LIVER DISEASES; MALE; METHANOL; MICE; MICE, INBRED BALB C; MUSCLE CONTRACTION; PARASYMPATHOLYTICS; PLANT EXTRACTS; RABBITS; WATER;

ACHILLEA MILLEFOLIUM; ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 33746015050     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1897     Document Type: Article

References (17)

1. Baquar SR. 1989. Medicinal and Poisonous Plants of Pakistan. Printas: Karachi, 8.
2. Beckingham JI, Ryder SD. 2002. Investigation of liver and biliary diseases. Br Med J 322: 32-36.
3. ++ antagonists. Gen Pharmacol 22: 177-181.
4. Fleckenstein A. 1977. Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle. Rev Pharmacol Toxicol 17: 149-166.
5. Gilani AH, Janbaz KH, Zaman M, Lateef A, Suria A, Ahmed HR. 1994. Possible presence of calcium channel blocker(s) in Rubia cordifolia: an indigenous medicinal plant. J Pak Med Assoc 44: 82-85.
6. Hishinuma I, Nagakawa JI, Hirota K. 1990. Involvement of tumor necrosis alpha in the development of hepatic injury in galactosamine sensitized mice. Hepatology 12: 1187-1191.
7. Hsuan SL, Kannan MS, Jeyaseelan S et al. 1999. Pasteurella haemolytica leukotoxin and endotoxin induced cytokine gene expression in bovine alveolar macrophages requires NF-kappa B activation and calcium elevation. Microb Pathog 26: 263-273.
8. Keppler DOR, Rudigier JFM, Erwin B, Decker K. 1970. The trapping of uridine phosphate by D-galactosamine, D-glucosamine and 2-deoxy-D-galactose. Eur J Biochem 17: 246-253.
9. Molle WV, Berghe JV, Brouckaert P, Libert C. 2000. Tumor necrosis factor-induced lethal hepatitis pharmacological intervention with verapamil, tannic acid, picotamide and K76COOH. Fed Eur Biochem Soc Lett 467: 201-205.
10. National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, 1-7.
11. Reitman F, Frankel S. 1957. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28: 56-63.
12. Said HM. 1982. Diseases of the Liver: Greco-Arabic Concepts. Hamdard Foundation Press: Karachi, 100-132.
13. Schanne FAX, Kane AB, Young EE, Farber JL. 1979. Calcium dependence of toxic cell death: A final common pathway. Science 206: 700-702.
14. Szabo C, Thiemermann C, Vane JR. 1993. Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem Biophys Res Commun 196: 825-830.
15. Szewczyk A, Wojtczak L. 2002. Mitochondria as a pharmacological target. Pharmacol Rev 54: 101-127.
16. Tiegs G, Woloter M, Wendel A. 1989. Tumor necrosis factor is the terminal mediator in galactosamine/endotoxin induced hepatitis in mice. Biochem Pharmacol 38: 627-631.
17. Zernig G, Graziadei I, Moshammer T, Zech C, Reider N, Glossmann H. 1990. Mitochondrial calcium antagonist binding sites are associated with an inner mitochondrial membrane. Mol Pharmacol 38: 362-369.